A new standard for the analysis and design of replication studies
暂无分享,去创建一个
[1] L. Held. The assessment of intrinsic credibility and a new argument for p < 0.005 , 2018, Royal Society Open Science.
[2] A Fletcher,et al. Implications for trials in progress of publication of positive results , 1993, The Lancet.
[3] Samantha F. Anderson,et al. Addressing the “Replication Crisis”: Using Original Studies to Design Replication Studies with Appropriate Statistical Power , 2017, Multivariate behavioral research.
[4] Christopher D. Chambers,et al. Redefine statistical significance , 2017, Nature Human Behaviour.
[5] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.
[6] A O'Hagan,et al. Bayesian Assessment of Sample Size for Clinical Trials of Cost-Effectiveness , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[7] S. Greenland. Bayesian perspectives for epidemiological research , 2006 .
[8] Alice C. Harris,et al. What is Reproducibility , 2006 .
[9] Eric-Jan Wagenmakers,et al. Replication Bayes factors from evidence updating , 2018, Behavior Research Methods.
[10] Robbie C. M. van Aert,et al. Bayesian evaluation of effect size after replicating an original study , 2017, PloS one.
[11] Gideon Nave,et al. Evaluating replicability of laboratory experiments in economics , 2016, Science.
[12] V. Johnson. Revised standards for statistical evidence , 2013, Proceedings of the National Academy of Sciences.
[13] Michael B. Yaffe,et al. Reproducibility in science , 2015, Science Signaling.
[14] R. Batra,et al. Absence of Evidence Is Not Evidence of Absence , 2019, The American journal of bioethics : AJOB.
[15] I. Good. The Bayes/Non-Bayes Compromise: A Brief Review , 1992 .
[16] L. Stein,et al. Probability and the Weighing of Evidence , 1950 .
[17] Sander Greenland,et al. Null misinterpretation in statistical testing and its impact on health risk assessment. , 2011, Preventive medicine.
[18] Brian A. Nosek,et al. Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.
[19] Brian A. Nosek,et al. Evaluating the replicability of social science experiments in Nature and Science between 2010 and 2015 , 2018, Nature Human Behaviour.
[20] Michael C. Frank,et al. Estimating the reproducibility of psychological science , 2015, Science.
[21] Michael Evans,et al. Checking for prior-data conflict , 2006 .
[22] M. J. Bayarri,et al. Bayesian Design of “Successful” Replications , 2002 .
[23] D. Spiegelhalter,et al. A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. , 1986, Statistics in medicine.
[24] L. Held. p-Values for Credibility , 2017, 1712.03032.
[25] Felix D. Schönbrodt,et al. Bayes factor design analysis: Planning for compelling evidence , 2016, Psychonomic Bulletin & Review.
[26] David J. Spiegelhalter,et al. Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.
[27] U. Simonsohn. Small Telescopes , 2014, Psychological science.
[28] John P. A. Ioannidis,et al. What does research reproducibility mean? , 2016, Science Translational Medicine.
[29] Anthony O'Hagan,et al. Assurance in clinical trial design , 2005 .
[30] George E. P. Box,et al. Sampling and Bayes' inference in scientific modelling and robustness , 1980 .
[31] D. Colquhoun. The False Positive Risk: A Proposal Concerning What to Do About p-Values , 2018, The American Statistician.
[32] Rae Woong Park. Bayesian Approaches to Clinical Trials and Health-Care Evaluation (Statics in Practice)(2004), David J. Spiegelhalter et al., John Wiley and Sons. , 2006 .
[33] S. Goodman,et al. A comment on replication, p-values and evidence. , 1992, Statistics in medicine.
[34] J. Ioannidis. The Proposal to Lower P Value Thresholds to .005. , 2018, JAMA.
[35] L. Held. Reverse-Bayes analysis of two common misinterpretations of significance tests , 2013, Clinical trials.
[36] L. Kennedy‐Shaffer. When the Alpha is the Omega: P-Values, "Substantial Evidence," and the 0.05 Standard at FDA. , 2017, Food and drug law journal.
[37] Sander Greenland,et al. Bayesian perspectives for epidemiological research: I. Foundations and basic methods. , 2006, International journal of epidemiology.
[38] D. Spiegelhalter,et al. Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation , 2004 .
[39] R. Matthews,et al. Why should clinicians care about Bayesian methods , 2001 .
[40] Leonhard Held,et al. Adaptive power priors with empirical Bayes for clinical trials , 2017, Pharmaceutical statistics.
[41] D. Spiegelhalter,et al. Monitoring clinical trials: conditional or predictive power? , 1986, Controlled clinical trials.
[42] M. A. Best. Bayesian Approaches to Clinical Trials and Health‐Care Evaluation , 2005 .
[43] J. Leek,et al. What Should Researchers Expect When They Replicate Studies? A Statistical View of Replicability in Psychological Science , 2016, Perspectives on psychological science : a journal of the Association for Psychological Science.
[44] David Colquhoun,et al. The reproducibility of research and the misinterpretation of p-values , 2017, bioRxiv.
[45] I. Good. Good Thinking: The Foundations of Probability and Its Applications , 1983 .
[46] J. Ioannidis,et al. Reproducibility in Science: Improving the Standard for Basic and Preclinical Research , 2015, Circulation research.
[47] Eric-Jan Wagenmakers,et al. Bayesian tests to quantify the result of a replication attempt. , 2014, Journal of experimental psychology. General.
[48] Steven N. Goodman,et al. Aligning statistical and scientific reasoning , 2016, Science.
[49] Valen E. Johnson,et al. On the Reproducibility of Psychological Science , 2017, Journal of the American Statistical Association.
[50] R. Matthews,et al. Methods for Assessing the Credibility of Clinical Trial Outcomes , 2001 .
[51] R. A. Matthews. Beyond ‘significance’: principles and practice of the Analysis of Credibility , 2018, Royal Society Open Science.